Ms. Bain is the former Chief Financial Officer of Codiak Biosciences, Inc. Previously, Ms. Bain served as Chief Financial Officer of Avalanche Biotechnologies, where she led a successful initial public offering (IPO) and follow-on financing. Additionally, she served as Vice President of Finance, Business Operations, and Treasurer at bluebird bio, where she led a successful IPO and Series D financing.
Prior to bluebird bio, Ms. Bain held senior roles at Genzyme Corporation and was Vice President of Finance, Global Manufacturing and Operations, and Vice President of Finance, Genzyme Genetics. Earlier in her career, she held senior roles at Fidelity Investments, AstraZeneca, and Deloitte & Touche.
Ms. Bain also currently serves on the Board of Directors of Autolus Therapeutics. She is a Certified Public Accountant and earned a Bachelor of Science in Accounting and Business Administration, as well as an Honors degree in Accounting and Business Administration, from the University of the Free State, Bloemfontein, South Africa.
